fashion -WSS

fashion

author：fashion 2025-10-01 18:07:55 - browse：6961

Moderna's mResvia vaccine — The FDA has approved Moderna’s RSV vaccine for older adults. Moderna

The Food and Drug Administration on Friday approved Moderna’s vaccine to protect older adults against respiratory syncytial virus, or RSV, making this the company’s second licensed product.

The Moderna RSV vaccine, which will be marketed under the name mResvia, was approved for adults 60 and older. It is made using the same messenger RNA platform as Moderna’s other licensed product, its Covid-19 vaccine Spikevax.

“The FDA approval of our second product, mResvia, builds on the strength and versatility of our mRNA platform,” Moderna CEO Stéphane Bancel said in a statement.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： BioAge raises $170M for combination therapy with Zepbound

WSS

For pregnant people, addiction treatment shouldn't mean a call to child protective services

Medicare threatens to cut off funding for HCA's Mission hospital

Eli Lilly’s Zepbound improved liver scarring in mid

Structure Therapeutics oral GLP

Elevance PBM president out as customers face prescription chaos

Sutter Health’s antitrust win overturned by appeals court

hotspot

fashion

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Wikipedia

State Dept. review finds Biden bears some blame for Afghanistan failures

For Medicare Advantage, Democrats want stronger protections around AI

BioMarin wins approval for gene therapy to treat hemophilia A

KalVista pill reduced swelling 'attacks' caused by genetic disease

Trump demands the U.S. pay no more for drugs than other countries … again

Take antibiotics after sex, CDC recommends for certain risk groups

In age of alternative facts, a scholarly course on calling out crap

STAT wants to know your pick for a great summer read or listen

Bright Health sells Medicare Advantage business to Molina

What should King Charles tell the public about his cancer?

entertainment

Biogen Alzheimer’s drug launch off to slow start

How digital tools helped lower hypertension in marginalized patients

Gilead acquiring CymaBay and its liver disease drug for $4.3 billion

Finland to offer bird flu vaccine to select groups of people, a possible global first

KalVista pill reduced swelling 'attacks' caused by genetic disease

Take antibiotics after sex, CDC recommends for certain risk groups

hotspot

focus

knowledge

hotspot